65,437 trials
Benign Breast Disease · Fibrocystic Disease of Breast · Fibroadenoma
Primary: Number of Participants Analysed for Reduction in Lump Size ( 60% Reduction in Lump Size Considered to be a Satisfactory Response) — 63; 61; 54; 14 participants
Idiopathic Parkinson Disease
Primary: Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Part III at Visit 7 (Month 33) — -2.5; -2.5; -2.2; -5.6 units on a scale
Upper Limb Amputation
Primary: Sternal Displacement During Towel Folding Task — 1.0; 1.06; 0.88 meters
Alzheimer's Disease
Primary: Change in Caregiver Burden From Baseline — 32.04; 28.59; 32.52; 27.55 units on a scale — p=.51
Pancreatic Endocrine Neoplasms
Primary: Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms — 28; 12; 22; 18 participants
Breast Cancer
Primary: Disease-free Survival — 64; 71; 70 percentage of participants
Healthy
Primary: Unsolicited Adverse Event Reports — 3; 4 Unsolicited Adverse Event Reports
Posttraumatic Stress Disorder
Primary: Clinical Assessed PTSD Scale (CAPS-2) — 20.10; 8.84 change in units on scale
Procedural Sedation
Primary: Clinical Interventions During Sedation — 41; 33; 48 Clinical interventions performed
Adult Primary Hepatocellular Carcinoma · Advanced Adult Primary Liver Cancer · Localized Unresectable Adult Primary Liver Cancer
Primary: Proportion of Patients Demonstrating Objective Response (PR+CR) as Defined by RECIST — 0 patients
Post-surgical Dental Pain
Primary: Sum of Pain Relief and Pain Intensity Differences From 0 to 6 Hours (SPRID 6 Hours) — 16.08; 12.42; 4.63 Score on a scale — p=0.0009
Renal Failure Chronic Requiring Hemodialysis
Primary: Change From Baseline Hemoglobin at End-of-Treatment: Least-Squares Mean — 0.6; -3.0 grams per liter — p=0.011
Sciatica
Primary: Oswestry Disability Index, v2 — -19.0; -13.3 units on a scale
Obstructive Sleep Apnea
Primary: Apnea-hypopnea Index (AHI) — 5.92; 5.56 events / hour
Hypertension, Pulmonary
Primary: Number of Participants With First Adjudicated Clinical Failure (CF) Event, Death, Hospitalisation for Worsening PAH, Disease Progression, Unsatisfactory Long-term…